SCHEMBL24677337

SCHEMBL24677337

Cc1nc(-c2ccc(-c3cc4nc(C)nc(-c5ccccc5)c4c4ccccc34)cc2)c2cc3ccccc3cc2n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 4/20 0.41
ESR2 Q92731 3/20 0.41
ACACA Q13085 2/20 0.39
KDM4E B2RXH2 4/20 0.38
LMNA P02545 3/20 0.38
ALDH1A1 P00352 3/20 0.38
MAPT P10636 2/20 0.38
WHR1 P49842 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
DHFR P00374 1/20 0.36
PDE10A Q9Y233 1/20 0.36
ADORA2A P29274 1/20 0.36
HSD17B10 Q99714 2/20 0.36
TP53 P04637 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36
HIF1A Q16665 1/20 0.36
PSMB5 P28074 1/20 0.35
HPGD P15428 1/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24395008 0.85 ESR1 (0.50) ESR1ESR2KDM4ELMNAALDH1A1
SCHEMBL23946319 0.80 KDM4E (0.47) KDM4ELMNAALDH1A1MAPTWHR1
SCHEMBL23946304 0.80 ADORA2A (0.45) ACACAKDM4ELMNAALDH1A1MAPT
SCHEMBL18907184 0.76 ESR1 (0.49) ESR1ESR2ACACAKDM4ELMNA
SCHEMBL23946246 0.75 KDM4E (0.49) KDM4ELMNAALDH1A1MAPTWHR1
SCHEMBL19169644 0.74 TYMS (0.44) KDM4ELMNAALDH1A1MAPTSMN1; SMN2
SCHEMBL23946336 0.74 PIK3CD (0.48) KDM4ELMNAALDH1A1MAPTPDE10A
SCHEMBL23946249 0.74 ADORA1 (0.43) KDM4ELMNAALDH1A1MAPTWHR1
SCHEMBL19169358 0.73 TYMS (0.46) KDM4ELMNAALDH1A1MAPTSMN1; SMN2
SCHEMBL23946306 0.73 KDM4E (0.53) KDM4ELMNAALDH1A1MAPTPDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220336747-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2022-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220336747-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD1, OCIAD2, OSBP ESR1 69/4885ESR2 160/4885ACACA 1865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.